Acer MedicalROCO:6857 51 Market Cap is NT$1,438.86 Mil as of Jul. 07, 2026. GuruFocus rates ROCO:6857 with a GF Score™ of 51/100 and a GF Value™ of NT$262.55 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 692 Healthcare Providers & Services companies, Acer Medical ranks worse than 63.58% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Acer Medical's share price for the quarter that ended in Dec. 2025 was NT$99. Acer Medical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 15.23 Mil. Therefore, Acer Medical's market cap for the quarter that ended in Dec. 2025 was NT$1,507.37 Mil.
Acer Medical's quarterly market cap
declined
from Dec. 2024 (NT$2,162.09 Mil) to Jun. 2025 (NT$1,827.12 Mil) and
declined
from Jun. 2025 (NT$1,827.12 Mil) to Dec. 2025 (NT$1,507.37 Mil).
Acer Medical's annual market cap
declined
from Dec. 2023 (NT$2,816.81 Mil) to Dec. 2024 (NT$2,162.09 Mil) and
declined
from Dec. 2024 (NT$2,162.09 Mil) to Dec. 2025 (NT$1,507.37 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Acer Medical's Enterprise Value for Today is NT$1,262.79 Mil.
Acer Medical (ROCO:6857) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Acer Medical Market Cap Related Terms
Acer Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Acer Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6857 vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, Acer Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Acer Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Acer Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acer Medical (ROCO:6857) has a Market Cap of NT$1,438.86 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Acer Medical and its competitors. According to the industry distribution chart, Acer Medical ranks #440 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 63.6%.
Is Acer Medical's Market Cap too high?
Acer Medical's current Market Cap is NT$1,438.86 Mil. Based on the distribution chart, Acer Medical ranks #440 out of 692 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Acer Medical has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #440 out of 692 companies for Market Cap. This places Acer Medical in the lower half of its industry. The industry median Market Cap is 98.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 98.60, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Acer Medical and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 98.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current Market Cap is NT$1,438.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$262.55, compared to a current price of NT$94.50 — trading 64% below its estimated fair value. The current Market Cap is NT$1,438.86 Mil. Acer Medical's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current Market Cap is NT$1,438.86 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$94.50 is trading 64% below its estimated GF Value™ of NT$262.55.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
Market Cap: NT$1,438.86 Mil
GF Value™: NT$262.55 vs. price of NT$94.50 (64% below fair value)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
51GF Score
Get the complete analysis for ROCO:6857
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
